We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -6.06% | 0.775 | 0.75 | 0.80 | 0.825 | 0.775 | 0.83 | 611,345 | 15:32:48 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.35 | 1.39M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/5/2021 13:29 | Bluebird no mate this is a share not a dog haha .. hang in there bruv one day we may make some dosh here GLA .. | pal44 | |
25/5/2021 11:31 | Blueblood, You know what you must do. Sale! | barrie16 | |
25/5/2021 09:19 | Picked up a few more; needed to place order. Not easy to buy once again. Updates due should recover this back to the 10p region IMO | davethechef | |
25/5/2021 08:46 | This really is a dog of a share.... | blueblood | |
24/5/2021 12:46 | Exclusive interview with Nigel Theobald talking through their latest operations update: | ga_dti | |
23/5/2021 07:31 | Nope, that last announcement confirms that the technology is still nowhere near to commercialisation. Oh and have the particles ever been in a human yet....... | nobbygnome | |
22/5/2021 23:44 | Nothing changes here. Glad I sold out ages ago. | jimbobaroony | |
21/5/2021 10:13 | Must admit I thought yesterday was the start of a gradual increase in the share price - seems we will have to wait a little longer to shake out the sellers. | alloa2003 | |
20/5/2021 13:28 | Yes, a lot of risk now eliminated. Huge buys and ready for a rise up to 15p over the next couple of weeks. | stockt2 | |
20/5/2021 09:23 | If the price can hold at this level, or tick higher, it would have broken through the 9, 38 and 90 moving averages all within 2 days (broke 9 day moving average yesterday). VERY BULLISH and you dont see that very often! | alloa2003 | |
20/5/2021 09:18 | Does someone know something we dont? 20 May 2021 09:14 9.3401 400,000 Buy | alloa2003 | |
20/5/2021 08:46 | No surprise to see the short term punters bailing out and a softening of the price. However, once this has settled I think we will see the long term investors taking more of an interest. | alloa2003 | |
20/5/2021 08:44 | Interesting announcement today which indicates progress is being made. While we might have something of a new vacuum for a few months, aside from the patent news, this is all good news. The more progress the more this de-escalates the risk associated with the shares and hopefully we should start to see a gradual rise. | alloa2003 | |
20/5/2021 08:25 | It's not a commercial collaboration! | dplewis1 | |
20/5/2021 08:11 | Difficult to fathom such a lame reaction. | the drewster | |
20/5/2021 08:08 | https://twitter.com/ | hamidahamida | |
20/5/2021 07:24 | Hahaha. I attempted to sell my entire holdings yesterday and couldn't get a quote. Hahaha. | janestone | |
17/5/2021 15:58 | It does seem to be, on the surface at least, one of those shares overlooked by the market. There arent too many. The fact funds were raised at 8p - oversubscribed - in my view gives the shares some strong support. | alloa2003 | |
17/5/2021 14:21 | Wouldn't move a penny from N4P won't get much better risk reward anywhere else. | stockt2 | |
17/5/2021 13:05 | Why you ramping SYME on a N4P board? | alloa2003 | |
14/5/2021 20:31 | Expecting usa patent news imminently as around 5 weeks ago Nigel mentioned in an interview the patent was a few weeks off. My guess is next week we will be updated on something, be it patent or evotec. | stockt2 | |
12/5/2021 16:52 | Ordinary months or Nigel's N4P months..... | blueblood |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions